Fabricant de semie caravane, ainsi que de caisse billetterie de manège.
OCSiAl Europe S.à r.l.
OCSiAl is a global leader in single wall carbon nanotube technology, enhancing electrode density, charge/discharge power, cohesion, and lifespan.
Modern Creation Luxembourg S.A.R.L
GRUNDIG is the European trusted leader in innovative consumer electronics since 1945 established in Germany. Modern Creation Luxemburg own GRUNDIG trademark worldwide and offer licenses in the product rang of Automotives, Car Electronics & accessories, Smart Travel, Portable devices, Lightings, Mobile accessories, Solar & EV power.
Look2innovate SA
Look2innovate SA, a leader in museum guiding solutions with over 25 years of experience, offers the most advanced and innovative range of audioguides. Partners include the Centre des Monuments Nationaux, Uffizi, Prado, and more. Our product line features Android players, Interactive and versatile audioguides, directional speakers, and UV-C sanitizing systems. Contact: Bechara Yared, GM, at bechara.y@look2innovate.com or +32485941014
HITEC Luxembourg S.A.
HITEC Luxembourg develops and produces testing instruments used in R&D, product development and in quality control to measure physical and structural properties of rubber fillers. HITEC Luxembourg also offers commissioning, training and maintenance services world-wide for its instruments, and is an active member of ASTM committees D24 (CB) and D36 (rCB). HITEC products are used worldwide by all major producers of carbon black, recovered CB and rubber goods. Among our best-selling ASTM-compliant instruments are OAN/COAN oil absorptometer, pellet hardness tester, CB press for COAN and sieve residue testing devices. Our know-how in industrial engineering as well as our in-house manufacturing make HITEC Luxembourg also the ideal partner to develop and produce customer-specific solutions. HITEC Luxembourg also offers high technology solutions covering other business areas such as satellite ground segment, traffic management and mission critical, always with the same motto: market-oriented, client-centric and technology driven.
Faymonville Group
What began 7 generations ago as a small forge in Belgium is now trusted in over 125 countries worldwide. With full in-house production and vehicles built to handle the extraordinary, we deliver unmatched power and precision – from payloads of 33,000 lbs up to over 55 million lbs. MAX Trailer. Faymonville. Cometto. Three brands. One powerful team. One mission. We deliver trailers that perform – efficient, reliable, and ready to roll. Now, we’re your all-in-one partner in the USA with a production site in Arkansas. Welcome to the Faymily – now closer than ever.
FAREVA
Farera as a CDMO is providing a large service offer as sterile injectable and high potent, biological drug, conventionnal product, medial devices, foods supllements and probiotics as well as Drug substance manufacturing of recombinant protein, Andibody Dug Conjugason (ADC) with the associated Fill& Finish | FAREVA is a leading global pharmaceutical CDMO with industry leading capabilities in the development and manufacturing of a large range of Drug Products and Active Pharmaceutical Ingredients (APIs). FAREVA employs 13,000 people distributed in 41 production sites located in 13 countries in EMEA and the Americas. 16 of the FAREVA sites are dedicated to pharmaceutical activities. FAREVA’s API division has operations in 3 European sites located in France and Germany. | Fareva is a leading global pharmaceutical CDMO with a network of 16 manufacturing sites and 3 development sites throughout EMEA and the Americans. We offer comprehensive drug product and API services, including formulation development, clinical manufacturing, scale-up, and commercial manufacturing of small and large molecules. Our capabilities cover a wide range of dosage forms, such as OTC products, oral solid doses, non-sterile liquids and solids, ophthalmics, as well as sterile fill/finish and lyophilized presentations. In addition, our facilities have extensive expertise in secondary packaging, enabling us to serve as a fully integrated partner for our clients’ end-to-end pharmaceutical needs.